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The Ebola outbreak in West Africa (2013–
2016) triggered a renewed interest and sense 
of urgency about global health security. A 
surge of reports and publications ensued, 
examining various aspects of emerging infec-
tious disease outbreaks. In 2016, Olivero 
and colleagues published a biogeographical 
approach mapping favourable conditions 
that facilitated the Ebola outbreak, in terms 
of environmental factors and the presence of 
potential host animals.1 Constructing biolog-
ical vulnerability maps has value to guide 
preparations for future emerging infectious 
disease outbreaks, especially in low-income 
and middle-income countries. But perhaps 
more important is the need to develop similar 
‘vulnerability maps’ to capture the ability of 
health systems to prevent or respond to major 
infectious disease challenges. Without a 
health system vulnerability map, or the public 
availability of the data to generate it, efforts 
to achieve global health security in relation 
to emerging infectious disease outbreaks will 
likely be limited and post hoc, rather than 
pre-emptive and strategic. Unfortunately, 
the revived interest in global health security 
has not been matched with commensurate 
action. In 2014, the G7 (Group of Seven) 
endorsed the Global Health Security Agenda 
(GHSA), a partnership of governments and 
international organisations with the goal 
of accelerating the achievement of the core 
disease outbreak preparedness and response 
capacities as required by the International 
Health Regulations, but progress has been 
limited.
Formal assessment of countries’ compli-
ance with International Health Regulations 
is done through a Joint External Evaluation 
process. As part of this process, governments 
essentially assess themselves, followed by an 
independent international validation of the 
self-reported assessment. So far, 53 countries 
have initiated this Joint External Evaluation 
process. However, despite WHO reports 
that 43 Joint External Evaluation missions 
have been completed to date, including six 
GHSA-supported assessments completed in 
2015,2 just 23 completed evaluation reports 
are publicly available online. This exercise is 
limited in terms of the number of countries 
covered and the speed with which it is rolled 
out, but more importantly the evaluations are 
neither objectively quantifiable nor readily 
tracked and the relevant measures are only 
evaluated at the national level. Performance 
at the subnational level may be as, if not more, 
important. Indeed, as argued by Glassman 
and Lofgren (2016), “If we are serious about 
preventing the spread of emerging infectious 
diseases…, generating hard data on system 
performance—not just a rough qualitative 
approximation—is key to making this global 
effort successful.”3 It is important to have 
a regularly updated database of national 
and subnational data on key criteria that 
reflect countries’ preparedness and response 
capacity to disease outbreaks.
For this editorial, we examined the extent 
to which there is publicly available data on 
health system input and performance that 
could inform the judgement as to whether 
countries are adequately prepared for infec-
tious disease outbreaks or have sufficient 
response capacity. To do this, we searched 
online databases to assess which information 
would be readily available if there was an 
event that threatened regional/global health 
security originating in any given country. We 
included a measure of trust in governments 
because trust in government has featured 
prominently in analyses highlighting limita-
tions of national response to the West African 
Ebola outbreak.4–6 We also included factors 
related to existing accessibility of services 
(in terms of financial protection, availability 
of human resources for health, availability 
of drugs and supplies and quality of service 
delivery), because effective utilisation of, and 
trust in, healthcare services is essential to 
facilitate early case detection.7 Together with 
the quality of existing surveillance systems, we 
considered these elements to be the major 
determinants of early outbreak recognition 
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and the subsequent course of an outbreak. Further, these 
elements align with findings of an analysis conducted 
using the 2002–03 World Health Survey data which 
indicated that, together, five aspects of health system 
performance (technical quality, responsiveness, fair 
treatment, health outcomes, and financial protection) 
influenced citizens’ trust in their government.8
We selected the online databases of the WHO, the 
World Bank and Transparency International to screen 
for data that may provide proxies for these health system 
factors. We did not use data from the 2002 to 2003 World 
Health Survey because we considered it too dated and 
limited (the study was conducted in 70 countries). For 
human resources for health, we used data on doctors, 
nurses and midwives, community health workers and 
pharmaceutical personnel per 1000 people. For finan-
cial protection, we used out of pocket expenditure as a 
percentage of total expenditure on health. For surveil-
lance, we used tuberculosis treatment success rate for 
new cases and completeness of death registration with 
cause-of-death information. For drugs and supplies, we 
used the median availability of selected generic medi-
cines. For service delivery, we used hospital beds per 1000 
people, hospitals and health centres per 100 000 people, 
and antenatal care coverage (of at least four visits). And 
for our measure of trust, we used Transparency Interna-
tional’s Corruption Perception Index.
To assist global and national stakeholders take action on 
areas for which health systems require strengthening and 
investment, reputable data should be publicly available. 
What we found was not encouraging, especially in terms 
of data to reflect the current conditions of prepared-
ness and response capability for emerging infectious 
diseases. In the WHO and the World Bank databases, 
for instance, only four countries had data for 2015. By 
contrast, current (ie, for 2015) data from Transparency 
International’s Corruption Perception Index exists for 
168 countries (see table 1). Such a lack of up-to-date 
and publicly available data on proxies for health system 
capacity and infectious disease outbreak preparedness 
limits the possibility of mapping related vulnerabilities. 
This in turn limits our capacity to plan for, and invest in, 
health system strengthening that will promote resilience 
in the face of such outbreaks. To the best of our knowl-
edge, an equivalent endeavour to Olivero and colleagues’ 
mapping of biological vulnerability to Ebola has not been 
undertaken for other pathogens, or for biogeographical 
or health systems vulnerabilities.
It is important that data are collected at regular inter-
vals and made available for international review and 
transparency purposes. Efforts to assess and evaluate 
country-level compliance with the International Health 
Regulations are only one step in a more comprehensive 
evaluation process. The inclusion of subnational data 
and expansion beyond the input-focussed indicators of 
current International Health Regulations assessments are 
essential. These should include measures of trust (such 
as the Transparency International proxy used here) and 
Table 1 Data availability on health system investment and performance from WHO, World Bank and Transparency 
International
Health system investment 
and performance measures
Countries with publicly available data, n (%)
2015 – 2010 – 2014 2005 – 2009 2000 – 2004 1995 – 1999 – 1994 No Data
Doctors per 1000 0 (0%) 161 (74%) 13 (6%) 19 (9%) 12 (6%) 3 (1%) 11 (5%)
Nurses and midwives per 1000 0 (0%) 155 (71%) 16 (7%) 20 (9%) 2 (1%) 0 (0%) 26 (12%)
Community Health Workers 
per 1000
0 (0%) 14 (6%) 19 (9%) 38 (17%) 1 (0.5%) 1 (0.5%) 146 (67%)
Pharmaceutical personnel per 
1000
0 (0%) 100 (46%) 52 (24%) 26 (12%) 0 (0%) 0 (0%) 41 (19%)
OOP as % of health 
expenditure
0 (0%) 190 (87%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 29 (13%)
New TB treatment success 
rate
0 (0%) 187 (85%) 0 (0%) 3 (1%) 0 (0%) 0 (0%) 29 (13%)
Completeness of death 
registration
0 (0%) 88 (40%) 28 (13%) 2 (1%) 1 (0.5%) 0 (0%) 100 (46%)
Median availability of selected 
generic medicines
0 (0%) 38 (17%) (2007–13) 0 (0%) 0 (0%) 0 (0%) 181 (83%)
Hospital beds per 1000 0 (0%) 155 (71%) 31 (14%) 3 (1%) 5 (2%) 6 (3%) 19 (9%)
Hospitals per 1 00 000 0 (0%) 137 (63%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 82 (37%)
Health centres per 1 00 000 0 (0%) 112 (51%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 107 (49%)
Antenatal care coverage 4 (2%) 118 (54%) 20 (9%) 1 (0.5%) 0 (0%) 0 (0%) 76 (35%)
Corruption Perception Index 168 (76%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 52 (24%)
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evaluations of the interoperability of subnational and 
national healthcare and communication systems to assess 
the potential of rapid response during outbreaks. Efforts 
must also extend to the inclusion of animal surveillance 
and assessments of environmental determinants of poten-
tial emerging disease outbreaks.
How should these data be collected and curated? The 
scope of effort and cost of ensuring the currency and 
completeness of such a complex global data set is enor-
mous and, as recently argued in BMJ Global Health9 and in 
the Lancet,10 potentially beyond the operational capabili-
ties of the WHO. Yet the WHO has a critical role to play in 
terms of exercising normative authority.11 Here, we offer 
two (of several) possibilities. One, WHO could partner 
with the G7’s Global Health Security Agenda to conduct 
Joint External Evaluations to assess national compliance 
on a biennial basis, with regular surveys similar to the 
Demographic Health Surveys. Second, using the Global 
Burden of Disease model, WHO could partner with the 
Institute for Health Metrics and Evaluations and a vast 
network of (free) collaborators to endorse a new arm of 
the Global Burden of Disease endeavour, to produce a 
new biannual or tri-annual comparative health systems 
evaluation. To ensure a more sophisticated approach to 
evaluating health system capabilities, this could include 
collaborations with agencies such as Transparency 
International to fine tune and better focus assessments 
of health system processes and perceptions, including 
measures of trust in government on issues related to 
healthcare and infectious disease outbreak management.
To accelerate the achievement of outbreak prepared-
ness and response capacities, and to appropriately 
inform recent calls for improvements in global health 
security, such improvements in availability and complete-
ness of health system data must be accompanied by the 
investment necessary to strengthen health systems glob-
ally, at national and subnational levels. Further, these 
health system data should be integrated with biogeo-
graphical data, such as ecological and environmental 
data on potential areas of disease outbreak. With the 
focus of the Sustainable Development Goals on Universal 
Health Coverage, it is important to also emphasise the 
health systems strengthening requirements of global 
health security,12 and the links between achieving those 
and preparedness for outbreaks and resilience in the face 
of outbreaks.
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